Latest On Organovo Holdings, Inc (ONVO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-02-23 23:38 EST | News | Organovo, BICO reach licensing deal on bioprinting patents | N/A |  |
| 2021-07-21 18:18 EST | News | Organovo: New Strategy Targeting Internal Pipeline Development With Customized 3D Human Tissues Offers Upside | N/A | |
| 2021-07-21 18:18 EST | News | Organovo up 36% on bullish assessment of 3D human tissue biotech | N/A | |
| 2021-02-26 05:06 EST | News | GME, AMC, TNXP and NGA among premarket gainers | N/A | |
| 2021-02-18 01:23 EST | News | Cathie Wood’s ARK Investment raises Organovo stake | N/A | |
| 2021-02-10 08:11 EST | Financials | Company financials have been released. | Neutral | |
| 2021-01-17 22:39 EST | News | Activity Brewing At Organovo | N/A | |
| 2020-12-06 18:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 21:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 12:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 00:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 13:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-19 01:23 EST | Stock Split | A stock split has occured on Aug 19, 2020 with a split factor of 1:20. | Neutral | |
| 2020-08-17 11:10 EST | News | Organovo to reverse split shares 1:20 | N/A | |
| 2020-08-14 09:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-13 05:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 13:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 01:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 17:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 05:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 13:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 17:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 09:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 17:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-26 09:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 05:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 05:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-03 05:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 05:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 05:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 05:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-12 05:43 EST | News | Organovo stockholders nix Tarveda merger; shares up 2% after hours | N/A | |
| 2020-04-12 05:41 EST | News | Organovo Up On Cancelled Merger, And Other News: The Good, Bad And Ugly Of Biopharma | N/A | |
| 2020-04-09 05:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 21:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 04:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 21:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 00:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 00:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-13 00:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-11 22:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-07 00:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-01 00:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-29 00:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-28 04:40 EST | Earnings | Earnings have been released on June 8, 2017, with -$0.10 earnings per share. | Buy | |
| 2020-01-28 00:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-25 00:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-21 20:12 EST | Earnings | Earnings have been released on November 9, 2019, with -$0.05 earnings per share. | Buy | |
About Organovo Holdings, Inc (ONVO):
Organovo Holdings, Inc., a biotechnology company, develops bioprinted human tissues based on its 3D human tissue platform technology that emulate human biology and diseases. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases; and NovoTissues liver product using cells from a liver donor and cells from an umbilical cord donor. The company was founded in 2007 and is headquartered in Solana Beach, California.
General
- Name Organovo Holdings, Inc
- Symbol ONVO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 7
- Last Split Factor1:20
- Last Split Date2020-08-19
- Fiscal Year EndMarch
- IPO Date2012-02-14
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.organovo.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 280.53
- Price/Book (Most Recent Quarter) 4.08
- Enterprise Value Revenue 246.21
View More
Financials
- Most Recent Quarter 2020-12-31
- Return on Assets -27%
- Return on Equity -68%
- Earnings Per Share -$0.21
- Revenue Per Share $0
- Gross Profit -3416000
- Quarterly Earnings Growth -100%
View More
Highlights
- Market Capitalization 77.47 million
- EBITDA -25321000
- Analyst Target Price $3
- Book Value Per Share $2.92
View More
Share Statistics
- Shares Outstanding 7.12 million
- Shares Float 6.64 million
- % Held by Insiders 167%
- % Held by Institutions 41.62%
- Shares Short 511416
- Shares Short Prior Month 268053
- Short Ratio 1
- Short % of Float 9%
- Short % of Shares Outstanding 7%
View More
Technicals
- Beta 0.76
- 52 Week High $23.92
- 52 Week Low $4.3
- 50 Day Moving Average 13.74
- 200 Day Moving Average 10.69
View More
Dividends
- Dividend Date 2020-08-19
- ExDividend Date N/A
- Dividend Yield 0%
View More
Organovo Holdings, Inc (ONVO) Dividend Calendar:
ONVO's last dividend payment was made to shareholders on August 19, 2020.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Organovo Holdings, Inc (ONVO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-09 | $N/A | -$0.37 | ||
| 2020-09-30 | 2020-12-31 | $N/A | -$0.37 | ||
| 2020-06-30 | 2020-09-30 | $N/A | -$1.36 | ||
| 2020-03-31 | 2020-06-30 | $N/A | -$0.42 | ||
| 2019-12-31 | 2020-03-31 | $298000 | -$0.42 | ||
| 2019-09-30 | 2019-12-31 | $1.23 million | -$0.52 | -$1.20 | 56.95% |
| 2019-06-30 | 2019-08-08 | $668000 | -$1.00 | -$1.20 | 16.67% |
| 2019-03-31 | 2019-05-22 | $680000 | -$1.20 | -$1.30 | 7.69% |
| 2018-12-31 | 2019-02-07 | $779000 | -$1.20 | -$1.40 | 14.29% |
| 2018-09-30 | 2018-11-08 | $943000 | -$1.00 | -$1.50 | 33.33% |
| 2018-06-30 | 2018-08-09 | $689000 | -$1.40 | -$1.40 | 0% |
| 2018-03-31 | 2018-05-31 | $1.11 million | -$1.40 | -$1.47 | 4.55% |
| 2017-12-31 | 2018-02-08 | $1.15 million | -$1.40 | -$1.87 | 25% |
| 2017-09-30 | 2017-11-09 | $1.36 million | -$1.80 | -$2.00 | 10% |
| 2017-06-30 | 2017-08-09 | $990000 | -$2.00 | -$2.00 | 0% |
| 2017-03-31 | 2017-06-07 | $812000 | -$2.00 | -$2.20 | 9.09% |
| 2016-12-31 | 2017-02-09 | $1.15 million | -$1.80 | -$2.00 | 10% |
| 2016-09-30 | 2016-11-03 | $1.38 million | -$2.00 | -$2.00 | 0% |
| 2016-06-30 | 2016-08-04 | $891000 | -$1.80 | -$2.00 | 10% |
| 2016-03-31 | 2016-06-09 | $548000 | -$1.80 | -$2.20 | 18.18% |
| 2015-12-31 | 2016-02-08 | $328000 | -$2.20 | -$2.20 | 0% |
| 2015-09-30 | 2015-11-09 | $301000 | -$0.12 | -$0.10 | -20% |
| 2015-06-30 | 2015-08-10 | $306000 | -$0.10 | -$0.09 | -11.11% |
| 2015-03-31 | 2015-06-09 | $267000 | -$0.10 | -$0.09 | -11.11% |
| 2014-12-31 | 2015-02-06 | $155000 | -$0.09 | -$0.09 | 0% |
| 2014-09-30 | 2014-11-07 | $50000 | -$0.11 | -$0.09 | -22.22% |
| 2014-06-30 | 2014-08-12 | $99000 | -$1.64 | ||
| 2014-03-31 | 2014-06-10 | $115000 | -$0.08 | -$0.09 | 11.11% |
| 2013-12-31 | 2014-02-07 | $135000 | -$0.07 | -$0.09 | 22.22% |
| 2013-09-30 | 2013-11-27 | $23000 | -$2.86 | ||
| 2013-06-30 | 2013-08-28 | $106000 | -$1.16 | ||
| 2012-12-31 | 2012-12-31 | $349000 | -$4.43 | ||
| 2012-09-30 | 2012-09-30 | $469000 | $13.78 | ||
| 2012-06-30 | 2012-06-30 | $259000 | -$16.45 | ||
| 2012-03-31 | 2012-03-31 | $120000 | -$1.17 |
Organovo Holdings, Inc (ONVO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 402000 | N/A | N/A | -129000 | 145000 |
| Income Before Tax | -2.51 million | N/A | N/A | -2.72 million | -3.37 million |
| Selling General Administrative | 2.09 million | N/A | N/A | 3.02 million | 5.37 million |
| Gross Profit | N/A | N/A | N/A | N/A | 285000 |
| Ebit | -2.51 million | N/A | N/A | -2.89 million | -5.23 million |
| Operating Income | -2.49 million | N/A | N/A | -2.89 million | -5.23 million |
| Income Tax Expense | N/A | N/A | 2000 | N/A | N/A |
| Total Revenue | N/A | N/A | N/A | N/A | 298000 |
| Cost of Revenue | N/A | N/A | N/A | N/A | 13000 |
| Total Other Income Expense Net | -20000 | N/A | N/A | 83000 | 1.86 million |
| Net Income From Continuing Operations | -2.51 million | N/A | N/A | -2.72 million | -3.37 million |
| Net Income Applicable to Common Shares | -2.51 million | -8.95 million | -2.77 million | N/A | -3.37 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | 19000 | N/A | N/A |
| Change to Liabilities | 91000 | -610000 | N/A | 670000 | -933000 |
| Total Cash Flow from Investing Activities | 5000 | 2000 | N/A | 701000 | 26000 |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | -1000 | -8000 |
| Change to Operating Activities | -2.5 million | -141000 | N/A | -157000 | 573000 |
| Change in Cash | N/A | N/A | -3.19 million | 117000 | -5.14 million |
| Total Cash from Operating Activities | -7.15 million | -2.57 million | -3.21 million | -583000 | -5.16 million |
| Depreciation | N/A | N/A | 6000 | 757000 | 174000 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | 351000 | -59000 |
| Change to Account Receivables | N/A | N/A | 43000 | 465000 | 18000 |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 4.15 million | 919000 | N/A | 701000 | 1.37 million |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 829000 | N/A | N/A | 1.81 million | 2.36 million |
| Total Stockholder Equity | 20.75 million | N/A | N/A | 26.63 million | 28.95 million |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Assets | 21.58 million | N/A | N/A | 28.44 million | 31.31 million |
| Common Stock | 7000 | 7000 | 131000 | N/A | 130000 |
| Other Current Assets | 1.26 million | N/A | N/A | N/A | N/A |
| Retained Earnings | -293.7 million | -291.18 million | -282.23 million | -279.47 million | -276.74 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | 1.19 million | 1.14 million | 120000 | N/A | 206000 |
| Cash | 18.84 million | N/A | N/A | 27.36 million | 30.47 million |
| Total Current Liabilities | 829000 | 658000 | N/A | 1.81 million | 2.36 million |
| Other Stockholder Equity | -1000 | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 289000 | 22000 | N/A | N/A | N/A |
| Total Current Assets | 20.1 million | 19.49 million | N/A | 28.32 million | 31.11 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 20.75 million | 19.99 million | 24.79 million | N/A | 28.95 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 829000 | 201000 | N/A | 720000 | 822000 |
Organovo Holdings, Inc (ONVO) Chart:
Organovo Holdings, Inc (ONVO) News:
Below you will find a list of latest news for Organovo Holdings, Inc (ONVO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Organovo Holdings, Inc (ONVO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0.35 | CALL | 39 | 86 | 787.54 | FALSE | 0.35 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.1 | CALL | 2 | 67 | 715.07 | FALSE | 0.1 | 0 |
| 2024-05-17 | 2.5 | 1.44 | PUT | 0 | 9 | 465.12 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 601.72 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 6.2 | PUT | 0 | 0 | 580.09 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.1 | CALL | 27 | 223 | 234.39 | FALSE | 0.1 | 0 |
| 2024-06-21 | 5 | 0.26 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0.4 | CALL | 0 | 71 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 1.45 | PUT | 0 | 4 | 474.13 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 326.3 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 460.32 | TRUE | 0 | 0 |
| 2024-09-20 | 2.5 | 0.25 | CALL | 20 | 375 | 199.58 | FALSE | 0.2 | 4 |
| 2024-09-20 | 5 | 0.55 | CALL | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 7.5 | 0.1 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 2.5 | 1.7 | PUT | 0 | 2 | 0 | TRUE | 0 | 0 |
| 2024-09-20 | 5 | 0 | PUT | 0 | 0 | 177.4 | TRUE | 0 | 0 |
| 2024-09-20 | 7.5 | 0 | PUT | 0 | 0 | 243.8 | TRUE | 0 | 0 |
| 2024-12-20 | 2.5 | 0.3 | CALL | 6 | 1 | 169.55 | FALSE | 0.3 | 0 |
| 2024-12-20 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 5 | 0 | PUT | 0 | 0 | 189.1 | TRUE | 0 | 0 |
| 2024-12-20 | 7.5 | 0 | PUT | 0 | 0 | 202.11 | TRUE | 0 | 0 |
Latest ONVO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:31 PM EST | 2 | $1.99 |
| Jun 13, 2022 7:31 PM EST | 4 | $1.99 |
| Jun 13, 2022 7:31 PM EST | 97 | $1.99 |
| Jun 13, 2022 7:33 PM EST | 1 | $1.99 |
| Jun 13, 2022 7:34 PM EST | 1 | $1.99 |
Organovo Holdings, Inc (ONVO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-05-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1497253/000156459020027310/0001564590-20-027310-index.htm |
| 2020-02-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1497253/000000000020001253/0000000000-20-001253-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1497253/000103738920000048/0001037389-20-000048-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1497253/000110465920021153/0001104659-20-021153-index.htm |
| 2020-10-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1497253/000110465920113850/0001104659-20-113850-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1497253/000114036120002955/0001140361-20-002955-index.htm |
| 2020-01-29 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1497253/000119312520017578/0001193125-20-017578-index.htm |
| 2020-02-13 | S-4/A | Registration of securities, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000119312520034294/0001193125-20-034294-index.htm |
| 2020-02-13 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1497253/000119312520034312/0001193125-20-034312-index.htm |
| 2020-02-20 | S-4/A | Registration of securities, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000119312520043665/0001193125-20-043665-index.htm |
| 2020-02-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1497253/000119312520043672/0001193125-20-043672-index.htm |
| 2020-02-24 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1497253/000119312520046655/0001193125-20-046655-index.htm |
| 2020-02-26 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000119312520049281/0001193125-20-049281-index.htm |
| 2020-02-26 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000119312520049287/0001193125-20-049287-index.htm |
| 2020-03-03 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000119312520059302/0001193125-20-059302-index.htm |
| 2020-03-16 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000119312520075007/0001193125-20-075007-index.htm |
| 2020-03-16 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000119312520075011/0001193125-20-075011-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1497253/000119312520080822/0001193125-20-080822-index.htm |
| 2020-03-20 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000119312520080824/0001193125-20-080824-index.htm |
| 2020-03-20 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000119312520080840/0001193125-20-080840-index.htm |
| 2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1497253/000119312520193012/0001193125-20-193012-index.htm |
| 2020-07-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1497253/000119312520193013/0001193125-20-193013-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120011300/0001209191-20-011300-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120011302/0001209191-20-011302-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120011304/0001209191-20-011304-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120031010/0001209191-20-031010-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120031012/0001209191-20-031012-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120031013/0001209191-20-031013-index.htm |
| 2020-07-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120043396/0001209191-20-043396-index.htm |
| 2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120047289/0001209191-20-047289-index.htm |
| 2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120047291/0001209191-20-047291-index.htm |
| 2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120047292/0001209191-20-047292-index.htm |
| 2020-09-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051016/0001209191-20-051016-index.htm |
| 2020-09-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051020/0001209191-20-051020-index.htm |
| 2020-09-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051024/0001209191-20-051024-index.htm |
| 2020-09-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051027/0001209191-20-051027-index.htm |
| 2020-09-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051028/0001209191-20-051028-index.htm |
| 2020-09-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051029/0001209191-20-051029-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051041/0001209191-20-051041-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051045/0001209191-20-051045-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051047/0001209191-20-051047-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051049/0001209191-20-051049-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051050/0001209191-20-051050-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051051/0001209191-20-051051-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051052/0001209191-20-051052-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000120919120051053/0001209191-20-051053-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1497253/000121465920001200/0001214659-20-001200-index.htm |
| 2020-03-03 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1497253/000149315220003257/0001493152-20-003257-index.htm |
| 2020-02-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1497253/000156459020004042/0001564590-20-004042-index.htm |
| 2020-03-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1497253/000156459020013657/0001564590-20-013657-index.htm |
| 2020-03-27 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000156459020013658/0001564590-20-013658-index.htm |
| 2020-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1497253/000156459020014668/0001564590-20-014668-index.htm |
| 2020-04-01 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000156459020014669/0001564590-20-014669-index.htm |
| 2020-04-01 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000156459020014670/0001564590-20-014670-index.htm |
| 2020-04-01 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000156459020014671/0001564590-20-014671-index.htm |
| 2020-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1497253/000156459020015914/0001564590-20-015914-index.htm |
| 2020-04-08 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1497253/000156459020015915/0001564590-20-015915-index.htm |
| 2020-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1497253/000156459020026401/0001564590-20-026401-index.htm |
| 2020-05-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1497253/000156459020027310/0001564590-20-027310-index.htm |
| 2020-07-24 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1497253/000156459020033385/0001564590-20-033385-index.htm |
| 2020-07-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1497253/000156459020034276/0001564590-20-034276-index.htm |
| 2020-08-06 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1497253/000156459020037697/0001564590-20-037697-index.htm |
| 2020-08-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1497253/000156459020037700/0001564590-20-037700-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1497253/000156459020038895/0001564590-20-038895-index.htm |
| 2020-08-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1497253/000156459020040373/0001564590-20-040373-index.htm |
| 2020-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1497253/000156459020040374/0001564590-20-040374-index.htm |
| 2020-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1497253/000156459020042513/0001564590-20-042513-index.htm |
| 2020-09-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1497253/000156459020042514/0001564590-20-042514-index.htm |
| 2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1497253/000156459020043777/0001564590-20-043777-index.htm |
| 2020-09-21 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1497253/000156459020044050/0001564590-20-044050-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1497253/000156459020051311/0001564590-20-051311-index.htm |
| 2020-07-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1497253/000181815320000001/0001818153-20-000001-index.htm |
| 2020-02-24 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1497253/999999999520000404/9999999995-20-000404-index.htm |
| 2020-03-03 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1497253/999999999720001118/9999999997-20-001118-index.htm |
| 2020-03-13 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1497253/999999999720001219/9999999997-20-001219-index.htm |